K08 CA222676/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2018	2
2019	4
2020	8
2021	13
2022	5
2023	4
2024	1

1

The MYC oncogene - the grand orchestrator of cancer growth and immune evasion.

Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM, Felsher DW. Dhanasekaran R, et al. Nat Rev Clin Oncol. 2022 Jan;19(1):23-36. doi: 10.1038/s41571-021-00549-2. Epub 2021 Sep 10. Nat Rev Clin Oncol. 2022. PMID: 34508258 Free PMC article. Review.

2

MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint.

Smith BAH, Deutzmann A, Correa KM, Delaveris CS, Dhanasekaran R, Dove CG, Sullivan DK, Wisnovsky S, Stark JC, Pluvinage JV, Swaminathan S, Riley NM, Rajan A, Majeti R, Felsher DW, Bertozzi CR. Smith BAH, et al. Proc Natl Acad Sci U S A. 2023 Mar 14;120(11):e2215376120. doi: 10.1073/pnas.2215376120. Epub 2023 Mar 10. Proc Natl Acad Sci U S A. 2023. PMID: 36897988 Free PMC article.

3

Battle of the biopsies: Role of tissue and liquid biopsy in hepatocellular carcinoma.

Lehrich BM, Zhang J, Monga SP, Dhanasekaran R. Lehrich BM, et al. J Hepatol. 2024 Mar;80(3):515-530. doi: 10.1016/j.jhep.2023.11.030. Epub 2023 Dec 15. J Hepatol. 2024. PMID: 38104635 Free PMC article. Review.

4

Genomic Landscape of HCC.

Nia A, Dhanasekaran R. Nia A, et al. Curr Hepatol Rep. 2020 Dec;19(4):448-461. doi: 10.1007/s11901-020-00553-7. Epub 2020 Nov 10. Curr Hepatol Rep. 2020. PMID: 33816052 Free PMC article.

5

Current and Emerging Tools for Hepatocellular Carcinoma Surveillance.

Adeniji N, Dhanasekaran R. Adeniji N, et al. Hepatol Commun. 2021 Dec;5(12):1972-1986. doi: 10.1002/hep4.1823. Epub 2021 Sep 17. Hepatol Commun. 2021. PMID: 34533885 Free PMC article. Review.

6

Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making.

Dhanasekaran R, Suzuki H, Lemaitre L, Kubota N, Hoshida Y. Dhanasekaran R, et al. Hepatology. 2023 Jun 12:10.1097/HEP.0000000000000513. doi: 10.1097/HEP.0000000000000513. Online ahead of print. Hepatology. 2023. PMID: 37300379

7

Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)-Multi-Omic and Singulomic Approaches.

Dhanasekaran R. Dhanasekaran R. Semin Liver Dis. 2021 Jan;41(1):9-18. doi: 10.1055/s-0040-1722261. Epub 2021 Jan 14. Semin Liver Dis. 2021. PMID: 33764481 Free PMC article. Review.

8

Implications of genetic heterogeneity in hepatocellular cancer.

Suresh A, Dhanasekaran R. Suresh A, et al. Adv Cancer Res. 2022;156:103-135. doi: 10.1016/bs.acr.2022.01.007. Epub 2022 Mar 7. Adv Cancer Res. 2022. PMID: 35961697 Free PMC article. Review.

9

Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy.

Dhanasekaran R, Nault JC, Roberts LR, Zucman-Rossi J. Dhanasekaran R, et al. Gastroenterology. 2019 Jan;156(2):492-509. doi: 10.1053/j.gastro.2018.11.001. Epub 2018 Nov 4. Gastroenterology. 2019. PMID: 30404026 Free PMC article. Review.

10

A Tale of Two Complications of Obesity: NASH and Hepatocellular Carcinoma.

Dhanasekaran R, Felsher DW. Dhanasekaran R, et al. Hepatology. 2019 Sep;70(3):1056-1058. doi: 10.1002/hep.30649. Epub 2019 May 27. Hepatology. 2019. PMID: 30958566 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year